4.7 Article

Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Urology & Nephrology

Molecular Mechanisms of Rhabdomyolysis-Induced Kidney Injury: From Bench to Bedside

Jessica F. Hebert et al.

Summary: This review discusses the mechanisms and clinical significance of rhabdomyolysis-induced acute kidney injury (RIAKI), as well as investigational treatments and ongoing research trials.

KIDNEY INTERNATIONAL REPORTS (2023)

Review Biotechnology & Applied Microbiology

Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population

Weixuan Zhao et al.

Summary: This article introduces the impact of epilepsy as a chronic brain disease on nearly 50 million people worldwide. Traditional antiepileptic drugs have various problems, and although new drugs have partially solved these issues, they cannot completely replace traditional drugs in clinical applications. Therefore, it is still important to continue using traditional antiepileptic drugs with individualized therapeutic plans.

BIOENGINEERED (2022)

Article Cell Biology

Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis

Qi Zhang et al.

Summary: This study discovered that ferroptosis, a programmed iron-dependent cell death mechanism, serves as a mechanism in statin-induced myopathy, and specifically identified atorvastatin as the statin that could lead to ferroptosis in human cardiomyocytes and murine skeletal muscle cells. The study highlights the importance of understanding the underlying pathophysiological mechanism of atorvastatin-induced myopathy and suggests that targeting ferroptosis could be a protective strategy for clinical application.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Biochemistry & Molecular Biology

Ferroptosis and its role in skeletal muscle diseases

Ying Wang et al.

Summary: This review provides a comprehensive summary of the mechanisms and signaling factors regulating ferroptosis, explores the role of ferroptosis in different skeletal muscle diseases, and highlights its potential as a therapeutic target. It is of great importance for understanding the pathogenesis of skeletal muscle diseases and developing clinical prevention and treatment strategies.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Medicine, General & Internal

Levetiracetam-Induced Rhabdomyolysis Following Medication Re-Initiation

Klayme-Shane Boucher et al.

Summary: This case report presents a patient who developed rhabdomyolysis after restarting levetiracetam (LEV). The symptoms of rhabdomyolysis improved after discontinuation of the medication, indicating a possible association with LEV use.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Review Medicine, General & Internal

Suspected Levetiracetam-Induced Acute Rhabdomyolysis in a Patient With Retinoblastoma: A Case Report and Literature Review

Khadija M. Alshehabi et al.

Summary: This report highlights a case of a 36-year-old male who developed severe rhabdomyolysis and acute kidney injury due to the use of levetiracetam for epilepsy treatment.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Chemistry, Medicinal

Quantitative Structure-Activity Relationship (QSAR) Model for the Severity Prediction of Drug-Induced Rhabdomyolysis by Using Random Forest

Yifan Zhou et al.

Summary: Drug-induced rhabdomyolysis (DIR) is a rare and potentially life-threatening muscle injury. Current predictive models for early detection of DIR have suboptimal performance due to the scarcity of cases. A proposed random forest (RF) model outperformed other methods in distinguishing drugs with DIR risk and can be a facilitated tool for early DIR detection.

CHEMICAL RESEARCH IN TOXICOLOGY (2021)

Review Biochemistry & Molecular Biology

Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy

Pierandrea Vinci et al.

Summary: Hyperlipidemia is a major risk factor for cardiovascular morbidity and mortality, and statins are the first-choice therapy for dyslipidemias. However, patient compliance is poor and statin-associated muscle symptoms are the most common side effect leading to treatment discontinuation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Clinical Neurology

What has been the impact of new drug treatments on epilepsy?

Zhibin Chen et al.

CURRENT OPINION IN NEUROLOGY (2020)

Article Medicine, General & Internal

Rhabdomyolysis

Brian Michael Cabral et al.

DM DISEASE-A-MONTH (2020)

Review Medicine, General & Internal

Suspected Levetiracetam-Induced Rhabdomyolysis: A Case Report and Literature Review

Imran A. Moinuddin

AMERICAN JOURNAL OF CASE REPORTS (2020)

Article Pediatrics

Levetiracetam Treatment-Associated Acute Rhabdomyolysis in an Adolescent

Nagehan Aslan et al.

JOURNAL OF PEDIATRIC INTENSIVE CARE (2020)

Review Pharmacology & Pharmacy

Levofloxacin-induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review

Jeannette Bouchard et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)

Article Medicine, General & Internal

A case of gabapentin overdose induced rhabdomyolysis requiring renal replacement therapy

Xiaoling Qiu et al.

CLINICAL CASE REPORTS (2019)

Article Medicine, General & Internal

Rhabdomyolysis: a rare adverse effect of levetiracetam

Liza Thomas et al.

BMJ CASE REPORTS (2019)

Letter Clinical Neurology

Levetiracetam-induced rhabdomyolysis: the first Italian case

Eugenia Rota et al.

NEUROLOGICAL SCIENCES (2018)

Article Clinical Neurology

HyperCKemia associated with lacosamide therapy in an elderly patient with focal onset epilepsy

Takashi Matsudaira et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)

Article Medicine, General & Internal

Rhabdomyolysis: A Rare Averse Effect of Levetiracetam

Vaibhav Rastogi et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2018)

Review Public, Environmental & Occupational Health

Proton Pump Inhibitors and Risk of Rhabdomyolysis

Scott J. Duncan et al.

DRUG SAFETY (2017)

Editorial Material Clinical Neurology

RHABDOMYOLYSIS ASSOCIATED WITH LEVETIRACETAM ADMINISTRATION

Rodica Di Lorenzo et al.

MUSCLE & NERVE (2017)

Review Medical Laboratory Technology

Non-traumatic rhabdomyolysis: Background, laboratory features, and acute clinical management

Gianfranco Cervellin et al.

CLINICAL BIOCHEMISTRY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiologic Findings in Gabapentin-Induced Myositis

Tyler Michael Coupal et al.

JOURNAL OF RADIOLOGY CASE REPORTS (2017)

Letter Clinical Neurology

Acute rhabdomyolysis associated with levetiracetam therapy in a child

Faruk Incecik et al.

ACTA NEUROLOGICA BELGICA (2016)

Review Pharmacology & Pharmacy

Rhabdomyolysis induced by antiepileptic drugs: characteristics, treatment and prognosis

Wei Jiang et al.

EXPERT OPINION ON DRUG SAFETY (2016)

Article Urology & Nephrology

A case of gabapentin-induced rhabdomyolysis requiring renal replacement therapy

Min Seok Choi et al.

Hemodialysis International (2016)

Letter Medicine, General & Internal

HyperCKemia induced by levetiracetam

Melanie Ramon et al.

PRESSE MEDICALE (2016)

Article Psychiatry

Rhabdomyolysis after lamotrigine overdose: a case report and review of the literature

Sokratis E. Karaoulanis et al.

ANNALS OF GENERAL PSYCHIATRY (2016)

Article Surgery

Pregabalin- and azithromycin-induced rhabdomyolysis with purpura: An unrecognized interaction: A case report

Kazuya Kato et al.

INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2016)

Article Pediatrics

Rhabdomyolysis in a Hospitalized 16-Year-Old Boy: A Rarely Reported Underlying Cause

Rishika Singh et al.

CASE REPORTS IN PEDIATRICS (2016)

Article Pharmacology & Pharmacy

Levetiracetam as a Possible Contributor to Acute Kidney Injury

Danielle C. Spengler et al.

CLINICAL THERAPEUTICS (2014)

Review Clinical Neurology

Statin myotoxicity: A review of genetic susceptibility factors

M. Needham et al.

NEUROMUSCULAR DISORDERS (2014)

Article Surgery

Biochemical markers of acute limb ischemia, rhabdomyolysis, and impact on limb salvage

J. Devin B. Watson et al.

SEMINARS IN VASCULAR SURGERY (2014)

Article Clinical Neurology

Creatine phosphokinase elevation exacerbated by levetiracetam therapy

Julia E. Isaacson et al.

EPILEPSY & BEHAVIOR CASE REPORTS (2014)

Article Clinical Neurology

A case of rhabdomyolysis in which levetiracetam was suspected as the cause

Hisanao Akiyama et al.

EPILEPSY & BEHAVIOR CASE REPORTS (2014)

Article Medicine, General & Internal

Pregabalin-associated rhabdomyolysis

Roshan Gunathilake et al.

MEDICAL JOURNAL OF AUSTRALIA (2013)

Article Pharmacology & Pharmacy

Drug induced rhabdomyolysis

Martin Hohenegger

CURRENT OPINION IN PHARMACOLOGY (2012)

Review Medical Laboratory Technology

Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features

Gianfranco Cervellin et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)

Review Medicine, General & Internal

Current Concepts: Rhabdomyolysis and Acute Kidney Injury.

Xavier Bosch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Pharmacology & Pharmacy

Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

DWJ Clark et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)